SPY310.52+2.16 0.70%
DIA257.31-0.56 -0.22%
IXIC10,154.63+95.86 0.95%

TG Therapeutics Q3 EPS $(0.69) May Not Compare To $(0.34) Estimate

TG Therapeutics (NASDAQ:TGTX) reported quarterly losses of $(0.69) per share which missed the analyst consensus estimate of $(0.34) by 102.94 percent. This is a 60.47 percent decrease over losses of $(0.43) per share

Benzinga · -

TG Therapeutics (NASDAQ:TGTX) reported quarterly losses of $(0.69) per share which missed the analyst consensus estimate of $(0.34) by 102.94 percent. This is a 60.47 percent decrease over losses of $(0.43) per share from the same period last year.